Natural Killer Cell and Extracellular Vesicle-Based Immunotherapy in Thyroid Cancer: Advances, Challenges, and Future Perspectives
Thyroid cancer, the most frequently occurring endocrine neoplasm, comprises a heterogeneous group of histological subtypes, spanning from the indolent papillary thyroid carcinoma (PTC) to the rapidly progressive and lethal anaplastic thyroid carcinoma (ATC). Although conventional therapies, such as...
Saved in:
| Main Authors: | Kruthika Prakash, Ramya Lakshmi Rajendran, Sanjana Dhayalan, Prakash Gangadaran, Byeong-Cheol Ahn, Kandasamy Nagarajan Aruljothi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/14/1087 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanomaterial assisted natural killer cell therapy
by: Xuan Yu, et al.
Published: (2025-05-01) -
Does a natural killer need a CAR?
by: Kangbo Wang, et al.
Published: (2025-06-01) -
CAR-NK cell therapy: promise and challenges in solid tumors
by: Sahar Balkhi, et al.
Published: (2025-04-01) -
The innate defenders: a review of natural killer cell immunotherapies in cancer
by: Pablo Álvarez-Carrasco, et al.
Published: (2024-12-01) -
Optimization of lentiviral delivery of barcoded anti-CD20 chimeric antigen receptors into rhesus macaque and human natural killer cells
by: Taha B. Hayal, et al.
Published: (2025-06-01)